A Human Brain-Chip for Modeling Brain Pathologies and Screening Blood–Brain Barrier Crossing Therapeutic Strategies

Shek Man Chim(Regeneron (United States)), Elias Pavlopoulos(Regeneron (United States)), Alexandros G. Kokkosis(Regeneron (United States)), Brian Zambrowicz(Regeneron (United States)), Kristen E. Howell(Texas A&M University), Katia Karalis(Regeneron (United States))
Pharmaceutics
October 10, 2024
10.3390/pharmaceutics16101314
Cited by 13

Related Papers

Engineered In Vitro Disease Models
|Annual Review of Pathology Mechanisms of Disease|2015|545
The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer
|Journal of Thoracic Oncology|2020|184
Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA
|BMJ Open|2021|56
EGFL7 Is Expressed in Bone Microenvironment and Promotes Angiogenesis via ERK, STAT3, and Integrin Signaling Cascades
|Journal of Cellular Physiology|2014|52
Functional biology of the Steel syndrome founder allele and evidence for clan genomics derivation of COL27A1 pathogenic alleles worldwide
|European Journal of Human Genetics|2020|39